Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

IMD 0354, Tocris Bioscience™

Catalog No. 261110
Click to view available options
Quantity:
10 mg
50 mg
This item is not returnable. View return policy
This item is not returnable. View return policy

Inhibitor of IKKβ

Inhibitor of IκB kinase-β (IKKβ) that blocks NF-κB nuclear translocation. Attenuates myocardial ischemia/reperfusion injury by decreasing expression of adhesion molecules ICAM-1 and P-selectin and inhibiting cytokine and chemokine production in cardiomyocytes. Induces G0/G1 cell cycle arrest and apoptosis in HMC-1 and breast cancer cells. Also antagonist at P2X1, P2X4 and P2X7 receptors (IC50 values are 19, 156 and 175 nM respectively). Inhibits platelet aggregation induced by collegen in vitro.

Chemical Identifiers

CAS 978-62-1
Molecular Formula C15H8ClF6NO2
Molecular Weight (g/mol) 383.67
MDL Number MFCD00218820
InChI Key CHILCFMQWMQVAL-UHFFFAOYSA-N
Synonym ikk-2 inhibitor v, n-3,5-bis trifluoromethyl phenyl-5-chloro-2-hydroxybenzamide, n-3,5-bis-trifluoromethylphenyl-5-chloro-2-hydroxybenzamide, benzamide, n-3,5-bis trifluoromethyl phenyl-5-chloro-2-hydroxy, kinome_1864, d0z5dm, 3',5'-salicyloxylidide, 5-chloro-alpha,alpha,alpha,alpha',alpha',alpha'-hexafluoro, imd hplc , solid
PubChem CID 5081913
IUPAC Name N-[3,5-bis(trifluoromethyl)phenyl]-5-chloro-2-hydroxybenzamide
SMILES OC1=C(C=C(Cl)C=C1)C(=O)NC1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F

Specifications

Quantity 10 mg
Formula Weight 383.67
Percent Purity >99%
Chemical Name or Material IMD 0354
Recommended Storage Store at +4°C
Provide Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.